Birchmere Ventures

Birchmere Ventures is a venture capital firm that invests in early-stage technology companies across the United States. With over $250 million under management, the firm focuses on building high-growth companies that make a positive impact while delivering strong returns for investors. Birchmere's portfolio companies have achieved a cumulative market valuation of $14 billion.

The firm's investment strategy centers on partnering with entrepreneurs to help build high-growth technology companies. Birchmere Ventures has offices in Pittsburgh, Pennsylvania, and San Francisco, California, and has funded innovative companies that make a positive impact while also delivering strong returns for investors.

Birchmere Ventures has a successful track record of investing in and building early-stage technology and life sciences companies. The firm focuses principally on early-stage, pre-revenue start-ups where they have direct operational or investing experience. They prefer to lead syndicated deals with other institutional investors. Birchmere Ventures has made over 50 investments, including companies like Cvent, TenMarks, CyOptics, Neolinear, and FreeMarkets, which have achieved significant market valuations and successful exits.